In the present study, MSH2 expression levels in SARC were significantly associated with genetic differences, tumor immune cell infiltration, and so on, and are likely to be used as target genes for early screening or even therapeutic targets in SARC, which can help improve more than the efficiency of early screening but also the overall survival of SARC patients. The gene discussed is MSH2; the disease is neoplasm.